TipRanks (Tue, 3-Feb 8:32 AM ET)
Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Twist Bioscience (TWST)
TipRanks (Tue, 3-Feb 8:02 AM ET)
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Business Wire (Tue, 3-Feb 8:00 AM ET)
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Tue, 3-Feb 4:20 AM ET)
Twist Bioscience Earnings Call Highlights AI-Driven Growth
TipRanks (Mon, 2-Feb 7:03 PM ET)
Analysts Are Bullish on Top Healthcare Stocks: Pelthos Therapeutics (PTHS), Twist Bioscience (TWST)
TipRanks (Mon, 2-Feb 1:30 PM ET)
Twist Bioscience: Solid Execution, Raised 2026 Outlook, and Discounted Valuation Support Buy Rating
TipRanks (Mon, 2-Feb 9:17 AM ET)
Twist Bioscience Delivers Fiscal Q1 2026 Results—Innovative Platform Drives Growth Focus
Market Chameleon (Mon, 2-Feb 2:52 AM ET)
Twist Bioscience GAAP EPS of -$0.50 misses by $0.07, revenue of $103.7M beats by $1.66M
Seeking Alpha News (Mon, 2-Feb 7:32 AM ET)
Cathie Wood's weekly recap: ramps up bets on JOBY, CRSP, pares ILMN, VCYT
Seeking Alpha News (Mon, 2-Feb 7:30 AM ET)
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Twist Bioscience trades on the NASDAQ stock market under the symbol TWST.
As of February 4, 2026, TWST stock price climbed to $48.12 with 2,080,539 million shares trading.
TWST has a beta of 1.19, meaning it tends to be more sensitive to market movements. TWST has a correlation of 0.10 to the broad based SPY ETF.
TWST has a market cap of $2.94 billion. This is considered a Mid Cap stock.
Last quarter Twist Bioscience reported $104 million in Revenue and -$.50 earnings per share. This beat revenue expectation by $974,498 and met earnings estimates .
In the last 3 years, TWST traded as high as $60.90 and as low as $11.46.
The top ETF exchange traded funds that TWST belongs to (by Net Assets): ARKK, ARKG, XBI, IWM, VTI.
TWST has underperformed the market in the last year with a return of -8.8%, while SPY returned +16.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TWST shares. However, TWST has outperformed the market in the last 3 month and 2 week periods, returning +52.4% and +15.5%, while SPY returned +0.7% and +1.3%, respectively. This indicates TWST has been having a stronger performance recently.
TWST support price is $44.55 and resistance is $48.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TWST shares will trade within this expected range on the day.